Insider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells $286,800.00 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal sold 30,000 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the transaction, the director now directly owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. This represents a 19.13 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $8.85 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The business has a fifty day simple moving average of $8.37 and a two-hundred day simple moving average of $7.54. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $10.44. The company has a market capitalization of $344.59 million, a P/E ratio of 32.78 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The business had revenue of $58.00 million during the quarter.

Hedge Funds Weigh In On Viemed Healthcare

Several hedge funds have recently made changes to their positions in VMD. Vanguard Group Inc. grew its position in shares of Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares in the last quarter. Kent Lake Capital LLC purchased a new position in Viemed Healthcare during the first quarter worth about $5,557,000. Wasatch Advisors LP grew its position in Viemed Healthcare by 19.6% during the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after buying an additional 303,277 shares in the last quarter. Penbrook Management LLC grew its position in Viemed Healthcare by 236.0% during the second quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock worth $1,517,000 after buying an additional 162,670 shares in the last quarter. Finally, Apis Capital Advisors LLC grew its position in Viemed Healthcare by 193.0% during the second quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock worth $1,535,000 after buying an additional 154,400 shares in the last quarter. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.